BASILICA was considered for the 67-year-old female patient, but UNICORN was seen as an overall better option. The full case study was published in Circulation: Cardiovascular Interventions.

While some heart failure medications are less effective in patients with concomitant atrial fibrillation, new research suggests that is not the case for dapagliflozin.

The FDA has been busy this month. Review some of the biggest FDA-related stories of October, including big news from scPharmaceuticals, Abiomed, Bristol Myers Squibb and MedAlliance, in our monthly roundup. 

The new guidance document was designed to help cardiologists and other clinicians deliver the best care possible when treating ASCVD patients who present with additional conditions that need to be considered. 

A new policy statement from the American College of Cardiology highlights the importance of career flexibility—including the ability to change hours or work responsibilities when necessary—for cardiologists of all ages. 

“This systemic failure is a global tragedy, as many premature deaths from CVD could be avoided,” one cardiologist said. 

Leslee Shaw, PhD, director of the Blavatnik Family Women's Health Research Institute, a professor of medicine at the Icahn School of Medicine at Mount Sinai, and a former president of both SCCT and ASNC, explains the sex differences in cardiovascular imaging presentations in women versus men. 

Recent research has revealed that the medium and long-term impact of an acute illness may be associated with cardiovascular events, such as venous thromboembolism, stroke and myocardial infarction.

Patients whose private data may have been stolen by a cyberprowler last December have filed a class action lawsuit against the radiology practice whose IT systems may have been hacked.